Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
探索评价感通颗粒治疗普通感冒(感冒风热证)有效性和安全性的随机、双盲、多中心Ⅱb期
[Translation] A randomized, double-blind, multicenter phase IIb study to evaluate the efficacy and safety of Gantong granules in the treatment of common cold (cold with wind-heat syndrome)
探索评价感通颗粒治疗普通感冒(感冒风热证)有效性和安全性
[Translation] To explore and evaluate the effectiveness and safety of Gantong Granules in treating common cold (cold with wind-heat syndrome)
100 Clinical Results associated with Shenzhen Xing'er Medical Technology Development Co., Ltd.
0 Patents (Medical) associated with Shenzhen Xing'er Medical Technology Development Co., Ltd.
100 Deals associated with Shenzhen Xing'er Medical Technology Development Co., Ltd.
100 Translational Medicine associated with Shenzhen Xing'er Medical Technology Development Co., Ltd.